Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-13-044741)

Filing Details

Accession Number:: 0001209191-13-044741
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-09-18 16:23:45
Reporting Period:: 2013-09-16

Filing Date:: 2013-09-18
Accepted Time:: 2013-09-18 16:23:45
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
861838	Idera Pharmaceuticals Inc.	IDRA	Biological Products, (No Disgnostic Substances) (2836)	043072298

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1328507	W Robert Karr	707 Dominion Drive St. Louis MO 63131		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-09-16	5,750	$1.76	6,299	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote

Footnotes

Includes 549 shares of common stock held by the Robert W. Karr Revocable Trust. The reporting person disclaims beneficial ownership of all shares held in this trust.
Shares purchased by the Jean G. Karr Revocable Trust dated June 22, 2005, of which the reporting person is trustee and beneficiary.